Abstract
The rate of cardiogenic embolism among all ischemic strokes is as high as 38%. Cardioembolic strokes are characterized by the higher magnitude of neurological deficit, the high risk of recurrent acute stroke, and a lethal outcome. This review deals with the etiopathogenesis of thrombus formation in the heart chambers, with current criteria for the verification of cardioembolic strokes, with the results of trials of new oral anticoagulants, and latest guidelines for antithrombotic therapy to prevent stroke. Special focus is given to secondary stroke prevention in patients with nonvalvular atrial fibrillation since it is atrial fibrillation that is the most common cause of cardioembolic stroke.
Highlights
Частота кардиогенной эмболии среди всех ишемических инсультов достигает 38%
Current approaches to antithrombotic therapy in patients with cardioembolic stroke A.N
The rate of cardiogenic embolism among all ischemic strokes is as high as 38%
Summary
Механические искусственные клапаны сердца Митральный стеноз и ФП ФП (кроме одиночной) Тромб ушка левого предсердия Синдром слабости синусового узла ИМ, давностью
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
